CED Life Science Conference 2018 - presenting at the Coulter Investment Forum
Sub-sector: Medical Devices
Year Founded: 2004
SFC Fluidics has developed a miniaturized microfluidics pump which will enable the Company to deliver 1) a more convenient and affordable insulin delivery system and 2) a “closed loop artificial pancreas system” that minimizes body burden while virtually eliminating manual intervention. In late 2017, the JDRF (Juvenile Diabetes Research Foundation) partnered with SFC and funded partial development of the artificial pancreas. SFC is uniquely positioned to provide accurate, reliable, user-friendly, and safe insulin dosing pumps. SFC’s breakthrough technology leverages design for manufacturability (no mechanical moving parts) and low-cost leadership through use of injection molded components sourced from the Company’s world-class manufacturing partner.
Anthony Cruz, CEO
Don Jackson, CFO
Greg Lamps , VP & Product Realization
Ashley Shemain, VP & Marketing and Business Development
- Prototype has been completed and tested in animals.
- Established a strategic manufacturing partner.
- Three patents and four patents pending.
- Obtained Phase 2 SBIR funding for the min-ePump. ($1.45 Million)
- Obtained JDRF funding for artificial pancreas development
Learn more about the CED Life Science Conference.